Rallis India (RALLIS) Q4 24/25 earnings summary

Executive summary

• Q4 FY25 revenue was INR 430 crore, down 1% year-over-year, with FY25 revenue at INR 2,663 crore, nearly flat from FY24.

• Q4 FY25 PAT was minus INR 32 crore, compared to minus INR 21 crore last year; FY25 PAT was INR 125 crore, down from INR 148 crore.

• Crop care B2C business saw 3% Q4 volume growth despite price pressures; exports recovered with 6% growth in Q4.

• Board recommended a dividend of Rs. 2.50 per share for FY 2024-25, subject to shareholder approval.

• Audited financial results for FY25 were approved with an unmodified opinion from statutory auditors.

Financial highlights

• FY25 revenue from operations was Rs. 2,663 crore, up from Rs. 2,648 crore in FY24; Q4 revenue was INR 430 crore, down 1% YoY.

• FY25 net profit was Rs. 125 crore, down from Rs. 148 crore; Q4 net loss was Rs. 32 crore, compared to Rs. 21 crore last year.

• Crop care B2C full-year revenue grew to INR 1,578 crore, up 4% YoY, with 9% volume growth.

• Soil and plant health revenue grew 23% to INR 220 crore; herbicide revenue rose 20% to INR 300 crore.

• Healthy cash and liquid funds balance of INR 439 crore as of March 31, 2025.

Outlook and guidance

• Positive domestic sentiment supported by above-normal reservoir levels and favorable monsoon forecasts.

• Focus on portfolio expansion, digital engagement, and new launches in high-growth segments like herbicides.

• Strategic emphasis on custom synthesis manufacturing (CSM) and expanding global reach to 70+ countries.

• Continued investment in R&D, process scale-up, and alliances to drive growth.

• No major greenfield or brownfield CAPEX planned; FY26 CAPEX expected at INR 75-100 crore, focused on solar and R&D.